Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women

This publication has 33 references indexed in Scilit:

• Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.
  Circulation, 1994
• Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.
  Proceedings of the National Academy of Sciences, 1994
• Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.
  Journal of Clinical Investigation, 1993
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
  Nature, 1992
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
  Journal of Clinical Investigation, 1992
• PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
  Nucleic Acids Research, 1992
• Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
  Circulation Research, 1991
• Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.
  Hypertension, 1990
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
  Journal of Clinical Investigation, 1990
• Angiotensin-converting enzyme: new concepts concerning its biological role
  Biochemistry, 1989